Anti-aging, which encompasses slow aging and reverse aging that youth cells, has become a health trend. While attention is ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

In conclusion, while weight loss medications such as semaglutide and tirzepatide offer promising short-term results, they often fail to deliver sustainable outcomes once treatment ends.

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

An important implication, for instance, is that if a person doesn’t respond well or experiences intolerable side effects with one weight loss medication, they have another option to try.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

So is it enough for a doctor to tell a chronically obese person to lose weight and leave it at that? Wyatt and Bray both point out that we routinely use medication for other conditions that can be ...

“It’s crazy,” she said of the ever-changing insurance landscape for weight-loss medications. “It’s absolutely insane to try to keep up with it all.” Across the country, doctors who ...

In a breakthrough study from Voy, in collaboration with Imperial College London, researchers have confirmed that combining digital behavioural support with weight loss medication can dramatically ...